Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

STOK holding history

Stoke Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

STOK overviewAll 13F holders of STOKFull Q2 2026 holdings

Shares (Q2 2026)
57,847
Value
$1.89M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of STOK by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202657,847$1.89M<0.1%+7,875+15.8%AddedHolders
Q1 202649,972$1.63M<0.1%+71+0.1%AddedHolders
Q4 202549,901$1.58M<0.1%−2,712−5.2%ReducedHolders
Q3 202552,613$1.24M<0.1%+21,917+71.4%AddedHolders
Q2 202530,696$348.4K<0.1%+30,696NewHolders
Q1 20250$00.0%−28,043−100.0%Sold outHolders
Q4 202428,043$309.3K<0.1%−143,203−83.6%ReducedHolders
Q3 2024171,246$2.10M<0.1%+34,236+25.0%AddedHolders
Q2 2024137,010$1.85M<0.1%−56,750−29.3%ReducedHolders
Q1 2024193,760$2.62M<0.1%+51,049+35.8%AddedHolders
Q4 2023142,711$750.7K<0.1%−62,455−30.4%ReducedHolders
Q3 2023205,166$808.4K<0.1%+88,701+76.2%AddedHolders
Q2 2023116,465$1.24M<0.1%+50,496+76.5%AddedHolders
Q1 202365,969$549.5K<0.1%−2,866−4.2%ReducedHolders
Q4 202268,835$635.3K<0.1%+42,700+163.4%AddedHolders
Q3 202226,135$336.0K<0.1%+26,135NewHolders
Q1 20220$00.0%−10,065−100.0%Sold outHolders
Q4 202110,065$241.0K<0.1%+10,065NewHolders
Q3 20210$00.0%−7,143−100.0%Sold outHolders
Q2 20217,143$240.0K<0.1%−4,714−39.8%ReducedHolders
Q1 202111,857$461.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.